{
    "2021-04-06": [
        [
            {
                "time": "",
                "original_text": "上市4年股价涨了8倍，健帆生物的高成长性已体现在销售模式中！",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "高成长性",
                        "销售模式"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-04",
                "original_text": "医药行业2021年4月投资月报：把握一季报最佳反弹窗口期 加配低估值且高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资月报",
                        "一季报",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：当前是反弹最佳窗口期 加配低估值高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物现1笔大宗交易 共成交6,913.00万元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "大宗交易",
                        "成交金额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "西南证券--健帆生物：业绩增速创历史新高，未来增长可期【公司研究】",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "业绩增速",
                        "历史新高",
                        "未来增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：核心资产景气回归 关注第二批耗材集采进程",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "核心资产",
                        "景气回归",
                        "耗材集采"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529)：年报业绩略超预期，扣非业绩加速增长",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "年报",
                        "业绩",
                        "超预期",
                        "扣非业绩",
                        "加速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}